Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8âºT Effector Memory Subset.
Alonso, Núria; Julián, María Teresa; Carrascal, Jorge; Colobran, Roger; Pujol-Autonell, Irma; Rodriguez-Fernández, Silvia; Teniente, Aina; Fernández, Marco Antonio; Miñarro, Antoni; Ruiz de Villa, María Carmen; Vives-Pi, Marta; Puig-Domingo, Manel.
; 10(11): e0142186, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26555789
Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth.
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
Evaluation of pharmacokinetic and pharmacodynamic parameters following single dose of sitagliptin in healthy Indian males.
Practical Asymmetric Synthesis of Sitagliptin Phosphate Monohydrate.
[Quantification of sitagliptin in human plasma and urine by LC-MS/MS method and its application].
The Effect of Sitagliptin on Lipid Metabolism of Fatty Liver Mice and Related Mechanisms.
The effects of DPP-IV inhibition in NOD mice with overt diabetes.
Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance.
Effect Of Sitagliptin On Glycemic Control, Body Weight, Blood Pressure And Serum Lipid Profile In Type 2 Diabetic Hyperlipidemic Patients.
Sitagliptin down-regulates retinol-binding protein 4 and reduces insulin resistance in gestational diabetes mellitus: a randomized and double-blind trial.